MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

499801

Report Date :

29.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

APPCURE LABS PRIVATE LIMITED

 

 

Registered Office :

Plot No.2, Survey No.93, Satyam Enclave Pet-Basheerabad Village, Quthbullapur Mandal, Hyderabad - 500055, Telangana

Tel. No.:

91-40-27230340

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

05.12.2012

 

 

Com. Reg. No.:

36-084625

 

 

Capital Investment / Paid-up Capital :

INR 5.180 Million

 

 

CIN No.:

[Company Identification No.]

U24232TG2012PTC084625

 

 

IEC No.:

4612000595

 

 

TIN No.:

36811001884

 

 

GST No.:

36AALCA3391AZW

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AALCA3391A

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Providing Research and Development and Drug and Pharmaceutical, Formulation Development Services. [Registered Activity and also Confirmed by Management]

 

 

No. of Employees :

64 [Approximately]

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 60000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2012. It is a subsidiary of Appco Pharma LLC.

 

The company is engaged in providing research and development and drugs and pharmaceutical formulation development services.

 

As per the financial records of 2017, the company has achieved a massive growth in its revenue as compared to the previous year’s revenue and has gained an average net profit margin of 2.65%.

 

The company possesses satisfactory financial position marked by sufficient net worth base along with debt free balance sheet profile, favourable gap between its trade payables and trade receivables and acceptable liquidity position.

 

Rating takes into consideration the strength that the company derives from its holding company and its experienced management team.

 

Business is active. Payment seems to be usually correct.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 29.03.2018.

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION PARTED BY

 

Name :

Mr. K Srinivasulu

Designation :

Purchase Manager

Contact No.:

91-9701451678

Date :

28.03.2018

 

 

LOCATIONS

 

Registered Office :

Plot No.2, Survey No.93, Satyam Enclave Pet-Basheerabad Village, Quthbullapur Mandal, Hyderabad - 500055, Telangana

Tel. No.:

91-40-27230340

Mobile No.:

91-9701451678 [Mr. K Srinivasulu]

Fax No.:

91-40-27230360

E-Mail :

anandssrao@gmail.com

purchase@appcurelabs.com

Website :

http://appcurelabs.com

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Srinivasa Rao Vankayalapati

Designation :

Whole-time Director

Address :

H No 3-5-83/7 Flat No 201 Virupas Mithila Apartment Kukatpally Vivekananda Nagar Cly, Hyderabad- 500072, Andhra Pradesh, India

Date of Birth:

01.07.1970

Date of Appointment :

05.12.2002

DIN No.:

03256980

Other Directorship :

CIN/FCRN

Company Name

Begin Date

End Date

U17200TG2011PTC074738

ARRIEN-RAJENDRA SPINNING MILLS PRIVATE LIMITED

30/05/2011

-

U24100AP2016PTC098568

NEW LINE MEDICINES PRIVATE LIMITED

19/03/2016

-

U24232TG2009PTC065531

ALVEUS PHARMACEUTICALS PRIVATE LIMITED

20/12/2010

-

U45200AP2010PTC071851

ARRIEN INFRASTRUCTURE INDIA PRIVATE LIMITED

23/12/2010

-

U45209TG2013PTC086726

ARRIEN HOMES PRIVATE LIMITED

01/04/2013

-

U73100TG2009PTC065273

OROS PHARMACEUTICALS PRIVATE LIMITED

20/12/2010

-

 

 

Name :

Mr. Appalaneni Rajendra Prasad

Designation :

Director

Address :

279 Hunting Ridge Rd Stamford Ct 06903 Us

Date of Birth:

01.01.1969

Date of Appointment :

05.12.2012

DIN No.:

03315589

Other Directorship :

CIN/FCRN

Company Name

Begin Date

End Date

U73100TG2009PTC065273

OROS PHARMACEUTICALS PRIVATE LIMITED

20/12/2010

-

U24232TG2009PTC065531

ALVEUS PHARMACEUTICALS PRIVATE LIMITED

20/12/2010

-

U45200AP2010PTC071851

ARRIEN INFRASTRUCTURE INDIA PRIVATE LIMITED

23/12/2010

-

U17200TG2011PTC074738

ARRIEN-RAJENDRA SPINNING MILLS PRIVATE LIMITED

30/05/2011

-

U45209TG2013PTC086726

ARRIEN HOMES PRIVATE LIMITED

01/04/2013

-

 

 

Name :

Mr. Komala Devi Vankayalapati

Designation :

Whole-time Director

Address :

H No 3-5-83/7 Flat No 201 Virupas Mithila Apartmen Vivekanand Nagar Colony Kukatpally, Hyderabad - 500072, Andhra Pradesh, India

Date of Appointment :

16.08.2014

DIN No.:

03429773

Other Directorship :

CIN/FCRN

Company Name

Begin Date

End Date

U24100AP2016PTC098568

NEW LINE MEDICINES PRIVATE LIMITED

19/03/2016

-

U45209TG2013PTC086726

ARRIEN HOMES PRIVATE LIMITED

30/09/2014

-

 

 

Name :

Mr. Srinivasa Rao Paruchuri

Designation :

Additional Director

Address :

12, Summerfield, Blvd Dayton, Nj 08810, New Jersey, 08810 Us

Date of Appointment :

07.06.2017

DIN No.:

07828314

 

 

KEY EXECUTIVES

 

Name :

Mr. K Srinivasulu

Designation :

Purchase Manager

 

 

Name :

Mr. J. Suresh

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2017

 

Names of Shareholders

No. of Shares

 

% age holding

Appalaneni Rajendra Prasad

9990

1.93

Vankayalapati Srinivasa Rao

10

0.00

Appco Pharma LLC

508000

98.07

 

 

 

Total

 

518000

100.00

 

 

AS ON: 30.09.2017

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters (Individual/Hindu Undivided Family - Indian)

1.93

Promoters (Body corporate)

98.07

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Providing Research and Development and Drug and Pharmaceutical, Formulation Development Services. [Registered Activity and also Confirmed by Management]

 

 

Products :

ITC Code No.

 

Product Descriptions

99811122

Research and experimental development services in biology

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

 

Selling :

Cheque

 

 

Purchasing :

Cheque

 

 

PRODUCTION STATUS: NOT AVAILABLE 

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

Pharma Companies

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

64 [Approximately]

 

 

Bankers :

 

Bank Name:

Kotak Mahindra Bank Limited

Branch:

Not Divulged

Person Name (with Designation):

--

Contact Number:

--

Name of Account Holder:

APPCURE LABS PRIVATE LIMITED

Account Number:

A/c No.: 744011019850

IFSC No.: KKBK0007530

Account Since (Date/ Year of A/c Opening):

--

Average Balance Maintained (Optional):

--

Credit Facilities Enjoyed (CC/OD/Term Loan):

--

Account Operation:

--

Remarks:

--

 

 

 

Auditors :

 

Name :

Eswaraiah and Company

Chartered Accountants

Address :

HIG 36, Phase V, KPHB Colony, Kukatpally, Hyderabad - 500085, Telangana, India

Tel. No.:

91-40-23390036

E-Mail :

contact@escas.in

Income-tax PAN of auditor or auditor's firm :

AABFE6104G

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding Company :

Appco Pharma LIC

 

 

CAPITAL STRUCTURE

 

AS ON: 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

INR 10/- each

INR 10.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

518000

Equity Shares

INR 10/- each

INR 5.180 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

5.180

5.180

5.180

(b) Reserves & Surplus

15.912

13.487

10.616

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

21.092

18.667

15.796

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

2.180

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

2.180

0.000

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

2.480

2.612

1.062

(c) Other current liabilities

30.224

48.750

32.909

(d) Short-term provisions

2.402

1.618

1.972

Total Current Liabilities (4)

35.106

52.980

35.943

 

 

 

 

TOTAL

58.378

71.647

51.739

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

38.527

30.852

35.045

(ii) Intangible Assets

0.000

0.000

0.004

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

1.938

1.746

(d)  Long-term Loan and Advances

2.635

2.345

2.018

(e) Other Non-current assets

1.856

1.282

1.401

Total Non-Current Assets

43.018

36.417

40.214

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

3.470

22.499

3.149

(c) Trade receivables

2.708

2.136

0.000

(d) Cash and cash equivalents

2.546

1.873

2.589

(e) Short-term loans and advances

6.512

8.722

5.787

(f) Other current assets

0.124

0.000

0.000

Total Current Assets

15.360

35.230

11.525

 

 

 

 

TOTAL

58.378

71.647

51.739

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Revenue from Operations

91.215

37.335

46.376

 

 

Other Income

0.077

0.003

0.096

 

 

TOTAL                                    

91.292

37.338

46.472

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

13.413

21.589

6.537

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

20.019

-20.019

0.000

 

 

Employees benefits expense

28.614

14.879

16.724

 

 

Direct expense

7.799

6.299

7.071

 

 

Other expenses

5.717

5.141

3.057

 

 

TOTAL                                    

75.562

27.889

33.389

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

15.730

9.449

13.083

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

0.198

0.034

0.074

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

15.532

9.415

13.009

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

4.975

4.579

4.367

 

 

 

 

 

 

PROFIT BEFORE TAX

10.557

4.836

8.642

 

 

 

 

 

Less

TAX                                                                 

8.138

1.737

0.043

 

 

 

 

 

 

PROFIT AFTER TAX    

2.419

3.099

8.599

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw materials

2.196

0.663

0.000

 

 

Spore parts

0.000

0.000

0.000

 

 

Capital

9.285

0.000

19.434

 

 

 

 

 

 

 

Earnings Per Share (INR)

4.67

5.54

36.76

 

Expected Sales (2017-2018): INR 200.000 Million [Due to business growth]

 

The above information has been parted by Mr. K Srinivasulu [Purchase Manager]

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Cash generated from operations

17.481

3.568

5.181

 

 

 

 

Net Cash from Operating Activities

13.738

0.296

3.808

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

10.84

20.88

0.00

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

33.68

17.48

0.00

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

67.49

44.16

59.30

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

4.53

0.42

4.15

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.41

0.31

0.37

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.60

0.74

0.69

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.00

0.00

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

1.66

2.84

2.28

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

1.83

1.65

2.22

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

79.44

277.91

176.80

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

2.65

8.30

18.54

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

4.14

4.33

16.62

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

11.47

16.60

54.44

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

0.44

0.66

0.32

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.34

0.24

0.23

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.36

0.26

0.31

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.00

0.00

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

0.44

0.66

0.32

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

5.180

5.180

5.180

Reserves & Surplus

10.616

13.487

15.912

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

15.796

18.667

21.092

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

46.376

37.335

91.215

 

 

-19.495

144.315

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

46.376

37.335

91.215

Profit

8.599

3.099

2.419

 

18.54%

8.30%

2.65%

 


LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

Yes

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

INDEX OF CHARGES: NO CHARGES EXISTS FOR COMPANY

 

 

CHANGE OF ADDRESS:

 

Registered address of the company has been shifted from Flat No: 201,3-5-83/7, Virupas MITHILA Apartment

Vivekananda Nagar Colony, Kukatpally Hyderabad - 500072, Andhra Pradesh, India to the present address w.e.f. 25.04.2013

 

COMPANY INFORMATION

 

The company is a private limited company incorporated under the provision of the companies Act, 2013. The company is engaged in the business of research and development of drugs and pharmaceutical and technology transfer as formula service provider.

 

CONTINGENT LIABILITIES:                            

 

Particulars

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

Bank guarantees issued by banks

0.905

0.905

 

 

FIXED ASSETS:

 

·         Land Equipment’s

·         Electrical Fittings

·         Furniture and Fixture

·         Office Equipment

·         Computer

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 65.04

UK Pound

1

INR 92.28

Euro

1

INR 80.62

                                         

 

                                                                 INFORMATION DETAILS

 

Information Gathered by :

SAV

 

 

Analysis Done by :

NYT

 

 

Report Prepared by :

ARC

           

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and opera     tions size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.